Perceptive Advisors’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Perceptive Advisors’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-2,322,247	Closed	-$158M	–	125
2022 Q3	$158M	Sell	2,322,247 -692,807	-23%	-$47.2M	4.59%	4
2022 Q2	$96.3M	Sell	3,015,054 -877,439	-23%	-$28M	3.02%	8
2022 Q1	$135M	Buy	3,892,493 +442,578	+13%	+$15.3M	2.7%	10
2021 Q4	$101M	Sell	3,449,915 -957,484	-22%	-$28M	1.56%	19
2021 Q3	$112M	Buy	4,407,399 +254,710	+6%	+$6.49M	1.63%	14
2021 Q2	$145M	Sell	4,152,689 -905,953	-18%	-$31.7M	1.89%	14
2021 Q1	$206M	Sell	5,058,642 -616,069	-11%	-$25.1M	2.61%	7
2020 Q4	$246M	Sell	5,674,711 -126,285	-2%	-$5.47M	2.64%	8
2020 Q3	$320M	Sell	5,800,996 -41,104	-0.7%	-$2.27M	4.67%	5
2020 Q2	$369M	Sell	5,842,100 -223,626	-4%	-$14.1M	5.98%	2
2020 Q1	$310M	Buy	6,065,726 +200,000	+3%	+$10.2M	8.07%	2
2019 Q4	$466M	Sell	5,865,726 -10,000	-0.2%	-$795K	9.26%	1
2019 Q3	$285M	Buy	5,875,726 +100,000	+2%	+$4.85M	7.68%	2
2019 Q2	$304M	Buy	5,775,726 +250,000	+5%	+$13.1M	6.97%	2
2019 Q1	$292M	Buy	5,525,726 +100,000	+2%	+$5.29M	8.25%	3
2018 Q4	$223M	Buy	5,425,726 +276,816	+5%	+$11.4M	8.48%	2
2018 Q3	$196M	Buy	5,148,910 +320,000	+7%	+$12.2M	5.23%	3
2018 Q2	$218M	Sell	4,828,910 -160,156	-3%	-$7.24M	5.72%	3
2018 Q1	$241M	Buy	4,989,066 +100,000	+2%	+$4.83M	6.75%	3
2017 Q4	$192M	Buy	4,889,066 +625,000	+15%	+$24.6M	6.38%	3
2017 Q3	$132M	Buy	4,264,066 +330,139	+8%	+$10.3M	5.06%	4
2017 Q2	$108M	Buy	3,933,927 +74,949	+2%	+$2.05M	5.41%	4
2017 Q1	$142M	Buy	3,858,978 +730,000	+23%	+$26.9M	8.1%	2
2016 Q4	$45.2M	Buy	3,128,978 +794,810	+34%	+$11.5M	3.22%	9
2016 Q3	$53.8M	Buy	2,334,168 +126,500	+6%	+$2.92M	3.47%	6
2016 Q2	$36.6M	Buy	2,207,668 +910,200	+70%	+$15.1M	2.54%	7
2016 Q1	$20.6M	Buy	1,297,468 +110,838	+9%	+$1.76M	1.8%	10
2015 Q4	$38.4M	Buy	1,186,630 +264,830	+29%	+$8.56M	2.84%	8
2015 Q3	$38.9M	Buy	+921,800	New	+$38.9M	3.1%	6